Title |
Improving lactose digestion and symptoms of lactose intolerance with a novel galacto-oligosaccharide (RP-G28): a randomized, double-blind clinical trial
|
---|---|
Published in |
Nutrition Journal, December 2013
|
DOI | 10.1186/1475-2891-12-160 |
Pubmed ID | |
Authors |
Dennis A Savaiano, Andrew J Ritter, Todd R Klaenhammer, Gareth M James, Amy T Longcore, Justin R Chandler, W Allan Walker, Howard L Foyt |
Abstract |
Lactose intolerance (LI) is a common medical problem with limited treatment options. The primary symptoms are abdominal pain, diarrhea, bloating, flatulence, and cramping. Limiting dairy foods to reduce symptoms contributes to low calcium intake and the risk for chronic disease. Adaptation of the colon bacteria to effectively metabolize lactose is a novel and potentially useful approach to improve lactose digestion and tolerance. RP-G28 is novel galacto-oligosaccharide (GOS) being investigated to improve lactose digestion and the symptoms of lactose intolerance in affected patients. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 6 | 40% |
United Kingdom | 2 | 13% |
France | 1 | 7% |
Brazil | 1 | 7% |
Costa Rica | 1 | 7% |
Unknown | 4 | 27% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 7 | 47% |
Members of the public | 7 | 47% |
Scientists | 1 | 7% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Italy | 2 | <1% |
Netherlands | 1 | <1% |
United States | 1 | <1% |
Unknown | 205 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 39 | 19% |
Researcher | 25 | 12% |
Student > Ph. D. Student | 16 | 8% |
Student > Master | 16 | 8% |
Other | 13 | 6% |
Other | 30 | 14% |
Unknown | 70 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 39 | 19% |
Agricultural and Biological Sciences | 33 | 16% |
Biochemistry, Genetics and Molecular Biology | 19 | 9% |
Nursing and Health Professions | 11 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 3% |
Other | 25 | 12% |
Unknown | 76 | 36% |